These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33130469)

  • 1. Generation of an NANS homozygous knockout human induced pluripotent stem cell line by the insertion of GFP-P2A-Puro via CRISPR/Cas9 editing.
    Bu Q; Zhang H; Liu Q; Dai Y; Wei Q; Xue A; Huang Y; Zhong K; Huang Y; Gao H; Cen X
    Stem Cell Res; 2020 Dec; 49():102052. PubMed ID: 33130469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a homozygous ABCA7-knockout human iPSC line using the CRISPR/Cas9 system.
    Guan M; Chai Y; Yi R; Chen Y; Ip JPK; Ye T; Chen Y
    Stem Cell Res; 2023 Feb; 66():103000. PubMed ID: 36521383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing.
    Feng H; Li Q; Margolis RL; Li PP
    Stem Cell Res; 2021 May; 53():102346. PubMed ID: 34087983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a homozygous ZBTB7A knockout human induced pluripotent stem line by CRISPR/Cas9 editing.
    Chen D; Song B; Cheng Y; Zhu L; Lu D; Liu N; Yang Y; Sun X
    Stem Cell Res; 2021 Aug; 55():102494. PubMed ID: 34403853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a homozygous ARHGAP11B knockout hiPSC line by CRISPR/Cas9 system.
    Liu Y; Jin Y; Chen T; Wu Y; Peng X; Li W; Wei S; Chen M; Zou Q; Guo S; Xu J; Tang C; Zhou X
    Stem Cell Res; 2022 May; 61():102764. PubMed ID: 35358830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a homozygous (MCRIi031-A-3) WT1 knockout human iPSC line.
    Pachernegg S; Robevska G; Ferreira LGA; van den Bergen JA; Vlahos K; Howden SE; Sinclair AH; Ayers KL
    Stem Cell Res; 2024 Sep; 79():103494. PubMed ID: 39003885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a homozygous HDAC6 knockout human embryonic stem cell line by CRISPR/Cas9 editing.
    Xie L; Huang J; Li X; Dai L; Lin X; Zhang J; Luo J; Zhang W
    Stem Cell Res; 2019 Dec; 41():101610. PubMed ID: 31775087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing.
    Lilianty J; Nur Patria Y; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
    Stem Cell Res; 2020 May; 45():101843. PubMed ID: 32446218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9.
    Gargano C; Vartanian-Grimaldi JS; Hovhannisyan Y; Joanne P; Agbulut O; Li Z; Parlakian A; Decaux JF
    Stem Cell Res; 2023 Dec; 73():103254. PubMed ID: 38035530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9.
    Fatima A; Schuster J; Akram T; Sobol M; Hoeber J; Dahl N
    Stem Cell Res; 2020 Apr; 44():101758. PubMed ID: 32203915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
    Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
    Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing.
    Bogomiakova ME; Sekretova EK; Eremeev AV; Shuvalova LD; Bobrovsky PA; Zerkalenkova EA; Lebedeva OS; Lagarkova MA
    Stem Cell Res; 2021 Aug; 55():102451. PubMed ID: 34237591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a FTO gene knockout human embryonic stem cell line using CRISPR/Cas9 editing.
    Wei C; Luo Q; Wang B; Long Y; Zhang M; Shan W; Yu X; Xu Y; Qian P; Huang H
    Stem Cell Res; 2021 May; 53():102362. PubMed ID: 34087991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of heterozygous (MCRIi031-A-1) and homozygous (MCRIi031-A-2) SOX9 knockout human iPSC lines.
    Pachernegg S; Robevska G; G A Ferreira L; van den Bergen JA; Vlahos K; Howden SE; Sinclair AH; Ayers KL
    Stem Cell Res; 2024 Sep; 79():103484. PubMed ID: 38924973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NANS-mediated synthesis of sialic acid is required for brain and skeletal development.
    van Karnebeek CD; Bonafé L; Wen XY; Tarailo-Graovac M; Balzano S; Royer-Bertrand B; Ashikov A; Garavelli L; Mammi I; Turolla L; Breen C; Donnai D; Cormier-Daire V; Heron D; Nishimura G; Uchikawa S; Campos-Xavier B; Rossi A; Hennet T; Brand-Arzamendi K; Rozmus J; Harshman K; Stevenson BJ; Girardi E; Superti-Furga G; Dewan T; Collingridge A; Halparin J; Ross CJ; Van Allen MI; Rossi A; Engelke UF; Kluijtmans LA; van der Heeft E; Renkema H; de Brouwer A; Huijben K; Zijlstra F; Heise T; Boltje T; Wasserman WW; Rivolta C; Unger S; Lefeber DJ; Wevers RA; Superti-Furga A
    Nat Genet; 2016 Jul; 48(7):777-84. PubMed ID: 27213289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a human induced pluripotent stem cell line with Cas9 driven by Tet-on operator via AAVS1 safe harbor gene-editing.
    Ding Y; Wang L; Ji W; Chen Z; Wang D; Chen C; Tong H; Han Z; Niu C; Chu M; Huang J; Guo X
    Stem Cell Res; 2020 Dec; 49():102064. PubMed ID: 33207306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing.
    Gulimiheranmu M; Li S; Zhou J
    Stem Cell Res; 2022 Jul; 62():102805. PubMed ID: 35576811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.